Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Artiva Biotherapeutics (ARTV) PT Lowered to $20 at Cantor Fitzgerald
-
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Starts Artiva Biotherapeutics (ARTV) at Overweight
-
Artiva Biotherapeutics (ARTV) Prices 13.92M Share IPO at $12/sh
-
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
